Are you Dr. Moncur?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
606 Stephen Sitter Ave
Silver Spring, MD 20910Phone+1 301-295-3776Fax+1 202-782-3217
Summary
- Dr. Joel Moncur, MD is a board certified pathologist in Silver Spring, Maryland. He is currently licensed to practice medicine in Indiana.
Education & Training
- Geisel School of Medicine at DartmouthClass of 1999
Certifications & Licensure
- IN State Medical License 2002 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Laboratory Considerations for Releasing Next-Generation Sequencing Data to Patients.Ann Moyer, Eric Loo, Evan Cadoff, Eric Konnick, Helena Duncan
Archives of Pathology & Laboratory Medicine. 2025-02-01 - Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices.Amy L Austin, Russell R Broaddus, Rhona J Souers, Megan E Kane, Ravindra Kolhe
American Journal of Clinical Pathology. 2025-01-28 - 2 citationsA selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer.Sushant Patkar, Stephanie Harmon, Isabell Sesterhenn, Rosina Lis, Maria Merino
Journal of Pathology Informatics. 2024-12-01
Authored Content
- Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
- Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
Press Mentions
- Searching for Clues Under the Microscope to Understand COVID-19June 12th, 2020